Table 1

Patient details, summary of response and final diagnosis at follow up

SubjectSexOnsetAge of onset (y)Duration (months)FVC (%)AbFascAtrophyCrampsReflexesDiagnosis at follow up
Proximal/ distalUpper/ lower limbUnilateral/ bilateral
1FDistalLowerUnilateral6012083NegNoYesYesSMA
2MDistalUpperUnilateral359482NegYesYesNoNALS
3MProximalUpperBilateral489384PosYesYesYesALS
4MDistalUpperUnilateral4512992PosNoSelectiveYesMMN
5MDistalUpperBilateral582784NegYesYesYesALS
6FDistalUpperUnilateral3720100NegNoNoYesMMN
7MDistalUpperUnilateral621793NegYesYesYesALS
8FDistalUpperBilateral32105102NegNoYesNoNMMN
9FDistalUpperUnilateral2712101NegNoYesNoMMN?
10MDistalUpperUnilateral4381NKNegNoSelectivenoMMN
  • Duration=duration of disease; FVC=forced vital capacity; Ab=antiganglioside antibodies; Fasc=fasciculations, N=normal, ↓=reduced; selective atrophy indicates selective involvement of individual muscles within a myotome; NK=not known; SMA=spinal muscular atrophy; ALS=amyotrophic lateral sclerosis; MMN=multifocal motor neuropathy;